logo image
search icon
Global Positive Expiratory Pressure (PEP) Devices Market

Positive Expiratory Pressure (PEP) Devices Market Size, Share & Trends Analysis Report By Product Type (High-Pressure PEP (26-102cm H2O) Devices, Low-Pressure PEP (5-20cm H2O) Devices), By Application, By Region, And By Segment Forecasts, 2024-2031

Report ID : 1276 | Published : 2024-02-08 | Pages: 180 | Format:

The Positive Expiratory Pressure (PEP) Devices Market Size is valued at 1.08 Billion in 2023 and is predicted to reach 2.11 Billion by the year 2031 at a 9.0 % CAGR during the forecast period for 2024-2031.

PEP

Positive expiratory pressure therapy (PEP) is performed for airway clearance therapy. A participant in this therapy breathes through a portable mouthpiece or mask. This allows air to pass past the mucus in the lungs and away from the airway walls. The device facilitates unrestricted air passage and requires active inhaled air expiration against resistance. The growth in COPD prevalence due to increased smoking and drinking in industrialized countries, as well as the recent introductions of innovative oscillatory PEP, are pushing the positive expiratory pressure devices market. The rising frequency of chronic pulmonary disorders and technological developments drive market expansion. The PEP devices market is growing due to an ageing population and an increase in chronic disease occurrences.

However, in low-income countries, a lack of awareness regarding technologically advanced airway clearing medicines is projected to stymie the worldwide Positive Expiratory Pressure Devices market growth. Furthermore, the market is expected to advance due to the time-consuming old airway clearance techniques.

Market Segmentation:

The Positive Expiratory Pressure (PEP) Devices market is segmented on the basis of Product, Forms and Sales channels. By product, the market is segmented as Probiotics, Prebiotics, Enzymes and Other Products. The forms segment includes Capsules, Tablets, Liquid and Other Forms. On the basis of sales channel, the market is categorized into Modern Trade, Convenience Stores, Specialty Stores, Multi-brand Stores, Online Retailing and Other Sales Channels.

Based On Product Type, The High-Pressure PEP (26-102cm H2O) Segment Is Accounted As A Significant Contributor To The Positive Expiratory Pressure (PEP) Devices Market.

The global PEP devices market can be divided into two product types: high-pressure PEP (26-102cm H2O) and low-pressure PEP (5-20cm H2O). The high-pressure PEP category earned the most revenue, owing to increased patient compliance with high-pressure devices and increased bronchodilation achieved by pressures more significant than 26 cm H2O. The enhanced patient initiatives to shorten hospital stays are expected to grow the high-pressure PEP segment. PEP devices with high pressure are used to give high levels of positive expiratory pressure (PEP) to the lungs. These devices are commonly utilized in individuals suffering from the chronic obstructive pulmonary disease (COPD), asthma, or other respiratory disorders requiring improved airway clearance. High-pressure PEP devices can be mechanical or electrical, and they can generate the appropriate level of PEP through various processes. Some high-pressure PEPs can be modified to meet the needs of the patient's breathing by turning a knob on the device known as an expiratory resistance control valve, or ERV.

The COPD Segment Witnessed Growth At A Rapid Rate.

The market will be led by chronic obstructive pulmonary disease (COPD). COPD is caused by an obstruction in the airways, causing difficulty breathing, and is primarily caused by tobacco smoking. According to a 2019 WHO (World Health Organization) report, the chronic obstructive pulmonary disease is the third leading cause of death worldwide. Growing patient awareness for the creation of a shared platform for COPD sufferers is likely to boost the segment's growth during the forecast period.

In The Region, The North America Positive Expiratory Pressure (PEP) Devices Market Holds A Significant Revenue Share.

North America dominates the positive expiratory pressure (PEP) market because of the increasing patient awareness in the region. Some of the factors driving the oscillatory positive expiratory pressure (OPEP) market during the forecast period include the rising prevalence of chronic obstructive pulmonary disease (COPD), increasing technological advancements, rising prevalence of asthma, and continuous technological and research development. The increasing frequency of chronic illnesses, on the other hand, will create several opportunities, resulting in the rise of the positive expiratory pressure (PEP) market within the time period stated. Due to an expanding patient pool and raised spending on healthcare infrastructure development by developing countries, the Asia-Pacific region is projected to expand during the projected period.

Competitive Landscape

Some Major Key Players In The Positive Expiratory Pressure (PEP) Devices Market:

  • Smiths Medical, Inc. (ICU Medical),
  • Philips Respironics,
  • Monaghan Medical Corporation,
  • Cegla GmbH & Co. KG,
  • PARI GmbH,
  • AirPhysio,
  • Medica Holdings, LLC,
  • DR Burton Healthcare

Positive Expiratory Pressure (PEP) Devices Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 1.08 Billion

Revenue Forecast In 2031

USD 2.11 Billion

Growth Rate CAGR

CAGR of 9.0 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product Type, By Application

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Smiths Medical, Inc. (ICU Medical), Philips Respironics, Monaghan Medical Corporation, R. Cegla GmbH & Co. KG, PARI GmbH, AirPhysio, Medica Holdings, LLC, DR Burton Healthcare and SoloPep.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Positive Expiratory Pressure (PEP) Devices Market Snapshot

Chapter 4. Global Positive Expiratory Pressure (PEP) Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Market Dynamics - Drivers

4.3. Challenges/Restraints

4.4. Market Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2019 & 2031

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product Type:

5.2.1. High Pressure PEP (26-102cm H2O) Devices

5.2.2. Low Pressure PEP (5-20cm H2O) Devices

Chapter 6. Positive Expiratory Pressure (PEP) Devices Market Segmentation 2: Application Estimates & Trend Analysis

6.1. Application Analysis & Market Share, 2019 & 2031

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2031 for the following Application:

6.2.1. Chronic Obstructive Pulmonary Disease (COPD)

6.2.2. Asthma

6.2.3. Atelectasis

6.2.4. Bronchitis

6.2.5. Bronchiectasis

6.2.6. Cystic Fibrosis

6.2.7. Others

Chapter 7. Positive Expiratory Pressure (PEP) Devices Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2024-2031

7.1.2. North America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2024-2031

7.1.3. North America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2024-2031

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2024-2031

7.2.2. Europe Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2024-2031

7.2.3. Europe Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2024-2031

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2024-2031

7.3.2. Asia Pacific Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2024-2031

7.3.3. Asia Pacific Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2024-2031

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2024-2031

7.4.2. Latin America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2024-2031

7.4.3. Latin America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2024-2031

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2024-2031

7.5.2. MEA Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2024-2031

7.5.3. MEA revenue Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2024-2031

7.5.3.1. South Africa

7.5.3.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Smiths Medical (ICU Medical)

8.2.1.1. Company Overview

8.2.1.2. Financials

8.2.1.3. Product portfolio

8.2.1.4. Business strategy & Recent developments

8.2.2. Philips Respironics

8.2.3. Monaghan Medical Corporation

8.2.4. R. Cegla GmbH & Co. KG

8.2.5. PARI GmbH

8.2.6. AirPhysio

8.2.7. Medica Holdings, LLC

8.2.8. DR Burton Healthcare

8.2.9. SoloPep

8.3. List of Other Prominent Players

Segmentation of Positive Expiratory Pressure (PEP) Devices Market-

By Product Type

  • High Pressure PEP (26-102cm H2O) Devices
  • Low Pressure PEP (5-20cm H2O) Devices

Positive Expiratory Pressure (PEP) Devices Market

By Application

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Atelectasis
  • Bronchitis
  • Bronchiectasis
  • Cystic Fibrosis
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

Who are the Key Players in the Positive Expiratory Pressure (PEP) Devices Market?

The Positive Expiratory Pressure (PEP) Devices Market Size is valued at 1.08 Billion in 2023 and is predicted to reach 2.11 Billion by the year 2031

The Positive Expiratory Pressure (PEP) Devices Market is expected to grow at an 9.0 % CAGR during the forecast period for 2024-2031.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach